Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Kreft, Andreas; Neumann, Helmut; von Bach, Danjell Sartorius et al.
Histologic diagnosis and grading of esophageal acute graft-versus-host diseaseVIRCHOWS ARCHIV. Bd. 474. H. 3. 2019 S. 325-332
van der Sluis, Pieter Christiaan; Grimminger, Peter Philipp; van Hillegersberg, Richard et al.
Hybrid minimally invasive esophagectomy for esophageal cancer: less is moreJOURNAL OF THORACIC DISEASE. Bd. 11. 2019 S. S1935-S1937
Rule, Simon; Dreyling, Martin; Goy, Andre et al.
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow up from a pooled analysisHAEMATOLOGICA. Bd. 104. H. 5. 2019 S. E211-E214
Vewinger, Nadine; Huprich, Sabrina; Seidmann, Larissa et al.
IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor PatientsINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 20. H. 12. 2019
Grivas, Petros; Monk, Bradley J.; Petrylak, Daniel et al.
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current StateTARGETED ONCOLOGY. Bd. 14. H. 5. 2019 S. 505-525
Almstedt, K; Schmidt, M
Immunonkologie beim Mammakarzinom – von der Diagnose bis zur TherapieOnkologie heute. Bd. 12. 2019 S. 32-36
Heimes, AS; Almstedt, K; Schmidt, M
Immunonkologie beim triple-negativen MammakarzinomFrauenheilkunde up2date. Bd. 13. 2019 S. 339-349
Banys-Paluchowskil, Malgorzata; Krawczyk, Natalia; Friebe, Verena et al.
Immunotherapy for breast cancerGYNAKOLOGE. Bd. 52. H. 5. 2019 S. 343-353
Tannapfel, Andrea; Reinacher-Schick, Anke; Hacker, Ulrich et al.
Immunotherapy: New Options in Gastrointestinal Cancers?VISCERAL MEDICINE. Bd. 35. H. 1. 2019 S. 47-51
McNamara, M. G.; Lopes, A.; Wasan, H. et al.
Impact of anatomic site of biliary tract tumour origin and conditional probability of survival (CS): Results from 15 prospective advanced first-line clinical trialANNALS OF ONCOLOGY. Bd. 30. 2019 S. 274-274